Anixa Biosciences Inc (ANIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
| 04-2004 | 01-2004 | 10-2003 | 07-2003 | 04-2003 | |
| Sales | 102 | 39 | 48 | 83 | 22 |
| Cost of Goods | 32 | 15 | 68 | 31 | 16 |
| Gross Profit | 70 | 24 | -20 | 53 | 6 |
| Operating Expenses | 798 | 849 | 738 | 735 | 993 |
| Operating Income | -696 | -810 | -690 | -652 | -971 |
| Other Income | 1 | 1 | 1 | 1 | 1 |
| Pre-tax Income | -695 | -809 | -689 | -651 | -970 |
| Net Income Continuous | -695 | -809 | -689 | -651 | -970 |
| Net Income | $-695 | $-809 | $-689 | $-651 | $-970 |
| EPS Basic Total Ops | -0.25 | -0.25 | -0.25 | -0.25 | -0.25 |
| EPS Basic Continuous Ops | -0.21 | -0.25 | -0.21 | -0.21 | -0.33 |
| EPS Diluted Total Ops | -0.25 | -0.25 | -0.25 | -0.25 | -0.25 |
| EPS Diluted Continuous Ops | -0.21 | -0.25 | -0.21 | -0.21 | -0.33 |
| EBITDA(a) | $-691 | $-804 | $-684 | $-644 | $-962 |